Fourteen (11.6%) had IDH1-mutant WHO grade 3 or 4 astrocytomas, and 107 (88.4%) had IDH1 wild-type glioblastomas (IDHwt GBM). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).